We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Cross-linked Hydrogels Developed for 3D Printing

By LabMedica International staff writers
Posted on 08 Jan 2018
A team of Japanese biomedical engineers has developed a novel, enzyme-based three-dimensional printing method that enables in vitro growth of complex cellular structures.

Investigators at Osaka University (Japan) reported in the December 11, 2017, online edition of the journal Macromolecular Rapid Communications that they had developed a cytocompatible inkjet bio-printing approach that enabled the use of a variety of bio-inks to produce hydrogels with a wide range of characteristics.

Stabilization of bio-inks was obtained by using the enzyme horseradish peroxidase (HRP) to catalyze cross-linking within the hydrogel while consuming cytotoxic hydrogen peroxide (H2O2) in the process.

Three-dimensional cell-laden hydrogels were fabricated by the sequential dropping of a polymer-containing bio-ink that had been cross-linked through the enzymatic reaction and H2O2 onto droplets of another bio-ink that contained the polymer, HRP, and cells. More...
The HRP in the second drop neutralized the H2O2 carried over in the first drop. This approach promoted adhesion of the biological ink droplets and allowed printing of complex biological structures. The approximately 95% viability of mouse fibroblasts enclosed in a bio-ink hydrogel consisting of gelatin and hyaluronic acid derivatives and subsequent elongation of the cells demonstrated the suitability of this three-dimensional printing approach.

"Advances in induced pluripotent stem cell technologies have made it possible for us to induce stem cells to differentiate in many different ways," said senior author Dr. Makoto Nakamura, professor of biochemical engineering at Osaka University. "Now we need new scaffolds so we can print and support these cells to move closer to achieving full three-dimensional printing of functional tissues. Our new approach is highly versatile and should help all groups working to this goal."

Related Links:
Osaka University


Gold Member
Quantitative POC Immunoassay Analyzer
EASY READER+
Serological Pipet Controller
PIPETBOY GENIUS
New
Pan-Cancer Panel
TruSight Oncology 500
New
PlGF Test
Quidel Triage PlGF Test
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








DIASOURCE (A Biovendor Company)

Channels

Molecular Diagnostics

view channel
Image: The RNA-seq based diagnostic test for pediatric leukemia ensures better outcomes for children with this common cancer (Photo courtesy of Qlucore)

RNA-Seq Based Diagnostic Test Enhances Diagnostic Accuracy of Pediatric Leukemia

A new unique test is set to reshape the way Acute Lymphoblastic Leukemia (BCP-ALL) samples can be analyzed. Qlucore (Lund, Sweden) has launched the first CE-marked RNA-seq based diagnostic test for pediatric... Read more

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: A simple blood test could replace surgical biopsies for early detecion of heart transplant rejection (Photo courtesy of Shutterstock)

Blood Test Detects Organ Rejection in Heart Transplant Patients

Following a heart transplant, patients are required to undergo surgical biopsies so that physicians can assess the possibility of organ rejection. Rejection happens when the recipient’s immune system identifies... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.